PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Obstetrics & Gynecology Science10.5468/ogs.2015.58.2.1752015582175Endometrial cancer occurence five years after breast cancer in BRCA2 mutation patientSang Eun Oh, Soo Hyun Kim, Mee Seon Kim, Min Kyu Kimhttps://synapse.koreamed.org/DOIx.php?id=10.5468/ogs.2015.58.2.175, https://synapse.koreamed.org/pdf/10.5468/ogs.2015.58.2.175, http://synapse.koreamed.org/DOIx.php?id=10.5468/ogs.2015.58.2.175
Obstetrics & Gynecology Science10.5468/ogs.2015.58.4.3312015584331Comment on: Endometrial cancer occurrence five years after breast cancer in BRCA2 mutation patientMin Chul Choi, Mi Sun Kim, Gee Hoon Lee, Jun Mo Leehttps://synapse.koreamed.org/DOIx.php?id=10.5468/ogs.2015.58.4.331, https://synapse.koreamed.org/pdf/10.5468/ogs.2015.58.4.331, http://synapse.koreamed.org/DOIx.php?id=10.5468/ogs.2015.58.4.331
npj Breast Cancer10.1038/s41523-019-0139-1201951Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal CarcinomatosisPedro Exman, Robert M. Mallery, Nancy U. Lin, Heather A. Parsonshttp://www.nature.com/articles/s41523-019-0139-1.pdf, http://www.nature.com/articles/s41523-019-0139-1, http://www.nature.com/articles/s41523-019-0139-1.pdf
Breast Cancer Research10.1186/bcr38720013S1Constitutional genomic instability of 9p23-24 in BRCA2 mutation carriersL Savelyeva, M Schwabhttp://link.springer.com/content/pdf/10.1186/bcr387.pdf, http://link.springer.com/article/10.1186/bcr387/fulltext.html, http://link.springer.com/content/pdf/10.1186/bcr387.pdf
Breast Cancer Online10.1017/s1470903105002890200589Update on chemoprevention in BRCA1 and BRCA2 mutation carriersM. Stumacher, S. M. Domchekhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/S1470903105002890
Breast Cancer Research10.1186/bcr953200471Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer familiesHannaleena Eerola, Päivi Heikkilä, Anitta Tamminen, Kristiina Aittomäki, Carl Blomqvist, Heli Nevanlinnahttp://link.springer.com/content/pdf/10.1186/bcr953.pdf, http://link.springer.com/article/10.1186/bcr953/fulltext.html, http://link.springer.com/content/pdf/10.1186/bcr953.pdf
Clinical Breast Cancer10.1016/s1526-8209(11)70943-0200345311-312A Benefit of Letrozole in Postmenopausal Women After Five Years of Tamoxifen Therapy for Early-Stage Breast CancerHeather DeGrendele, Joyce A. O'Shaughnessyhttps://api.elsevier.com/content/article/PII:S1526820911709430?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820911709430?httpAccept=text/plain
Cancers10.3390/cancers1012047720181012477Screening BRCA1 and BRCA2 Mutation Carriers for Breast CancerEllen Warnerhttp://www.mdpi.com/2072-6694/10/12/477/pdf
Breast Cancer Research10.1186/bcr9520002S1A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical courseJ Hartikainen, V Kataja, A Mannermaahttp://link.springer.com/content/pdf/10.1186/bcr95.pdf, http://link.springer.com/article/10.1186/bcr95/fulltext.html, http://link.springer.com/content/pdf/10.1186/bcr95.pdf
Breast Cancer Research10.1186/bcr70200024Future possibilities in the prevention of breast cancer: Intervention strategies in BRCA1 and BRCA2 mutation carriersRosalind A Eeleshttp://link.springer.com/content/pdf/10.1186/bcr70.pdf, http://link.springer.com/article/10.1186/bcr70/fulltext.html, http://link.springer.com/content/pdf/10.1186/bcr70.pdf